Curaleaf Holdings, Inc. (CURA) Earnings Call Transcripts
Curaleaf Holdings, Inc.'s Latest Earnings Call - June 22, 2026
During Curaleaf Holdings, Inc.'s Annual General and Special Meeting of Shareholders held on June 22, 2026, several significant resolutions were approved, which could impact the company's future operations and governance structure. The company did not provide specific financial metrics such as revenue or earnings for the quarter or fiscal year. However, the meeting focused on strategic corporate changes, including the approval of a plan to redomicile the company from British Columbia to Delaware, which could have implications for its regulatory environment and shareholder structure. Additionally, the approval of a new stock incentive plan and an exchange program for stock options could affect employee compensation and shareholder equity.
Reported metrics
| Metric | Value |
|---|---|
| Number of Directors | 10 (inline) |
| Stock Options | 10,070,478 (inline) |
| Auditor Appointment | BDO USA, P.C. (neutral) |
Guidance from management
Management did not provide specific forward guidance on revenue or earnings. The focus was on strategic corporate changes, including the redomiciliation to Delaware and changes to stock incentive plans.
What management said
Now that voting is completed, we will take a short break of a minute or 2 so that the scrutineer can compile preliminary ballot results in respect of each business item. We will reconvene in a few moments with the scrutineers' preliminary ballot results. [Break]
What analysts pressed on
Analysts may be concerned about the implications of the redomiciliation to Delaware, particularly regarding regulatory compliance and potential impacts on shareholder rights. The lack of specific financial guidance could also be a point of concern.
Main topics on the call
- Redomiciliation to Delaware — Shareholders approved a plan of arrangement to move the company's domicile from British Columbia, Canada, to Delaware, USA. This change subjects the company to Delaware's corporate laws, potentially impacting its governa...
- Stock Incentive Plan Approval — The meeting approved the continued ability of the company to issue awards under its 2018 Stock and Incentive Plan. This includes unallocated awards, which are part of a rolling 10% evergreen plan, as per TSX requirements...
- Option RSU Exchange Program — An exchange program was approved to convert up to 10,070,478 stock options into restricted share units, potentially aligning employee incentives with shareholder interests.
- Board and Auditor Changes — Seven directors were elected, including two new members, Faith Charles and Torsten Grief. BDO USA, P.C. was appointed as the new auditor, replacing PKF O'Connor Davies, LLP.
Read the full Curaleaf Holdings, Inc. transcript (June 22, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CURA) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on TSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 32 calls on record spanning March 24, 2020 to August 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 32 Curaleaf Holdings, Inc. earnings call transcripts on record, spanning March 24, 2020 to August 5, 2026. Based on this history, Curaleaf Holdings, Inc. reports quarterly. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- CURA
- Exchange
- TSX
- Country
- CA
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 32
- First call
- March 24, 2020
- Most recent
- August 5, 2026
- Reporting cadence
- quarterly